Combination of Covishield-Covaxin more effective: AIG hospital study

The first pilot study from India analyzing Covaxin-Covishield mixed doses

Expectations and predictions for 2022

In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis

Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000

Manipal Hospital Delhi opens advanced cancer care centre

The hospital has recently launched Radionuclide therapy

CDSCO increases shelf life of Covaxin

The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO

Curran Biotech’s develops nano coating to combat Covid-19 variants

The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India

TeleRay and Radiobotics to provide radiology AI

TeleRay partners with Radiobotics, adding Artificial Intelligence to their pre-existing integrated best-in-class medical image and patient information distribution platform

Six benefits of Cloud Computing in the pharma industry

NephroPlus raises US $ 24 mn in E round to fund expansion

The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)